Author:
Yu Dianke,Green Bridgett,Marrone April,Guo Yongli,Kadlubar Susan,Lin Dongxin,Fuscoe James,Pogribny Igor,Ning Baitang
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557–2576 (2007).
2. Yu, M. C. & Yuan, J. M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127, S72–78 (2004).
3. Ning, B. et al. Toxicogenomics and cancer susceptibility: advances with next-generation sequencing. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 32, 121–158 (2014).
4. Nebert, D. W. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 60, 265–271 (1997).
5. Bartsch, H. et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9, 3–28 (2000).